Baldicantos, Baby Boy .

HRN: 24-25-44  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/23/2023
12/29/2023
IV
45mg
OD
Potentially Septic Newborn
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: